Hope Funds for Cancer Research is offering fellowships to postdoctoral scientists who propose to work on highly innovative research projects that challenge the traditional paradigms of understanding the causes, mechanisms, progression, disease markers or risk factors of the most difficult-to-treat cancers, including pancreatic, lung, liver, sarcomas, esophageal, brain, gastric, bone and ovarian cancers; and rare leukemias, lymphomas and MDS. The Trustees of the Hope Funds believe that funding research that could lead to breakthroughs in these areas and increase life expectancy in these types of cancers is at the core of its mission. The Fellowship Review Committee will consider each of the following criteria, with a strong emphasis on the innovation of the project, in evaluating candidates.
The Hope Funds for Cancer Research is awarding three-year fellowships with a stipend of $56,000 for the first year, $59,000 for the second year, and $62,000 for the third year. A travel grant of $1,500 will be awarded each year to each grantee for the purpose of attending conferences and/or scientific training meetings. All awards and stipends are made to the Institution for the support of the designated Fellow.
Hope Funds for Cancer Research does not permit deductions to cover administrative expenses from either stipend/fellowship or travel grants as a matter of policy. Supplementation of stipends is permitted from either Institution or Sponsor’s grants, but not by any other fellowship awards or grants. The total stipend should not exceed the level of support for other professionals at the same level of training in that institution. The Hope Funds for Cancer Research’s grants are intended for full-time research. The candidates must devote their principal time and effort to the Funds-supported research activities. Any activities in addition to this Fellowship should be clearly specified in the application and in the annual progress report. Fellows are not permitted to pursue additional degrees during the course of their fellowship. Should the Fellow and/or Sponsor wish to discontinue the project, leave the Institution or modify any aspect of the award, he or she must seek approval from the Hope Funds for Cancer Research in advance. Failure to comply with this requirement may jeopardize any future awards to Institution and/or Sponsor by the Fund.
Hope Funds for Cancer Research pays fellowships quarterly to the Institution. These fellowships do not constitute an employer-employee relationship between the Hope Funds for Cancer Research and the Fellow. Detailed annual scientific progress reports are due annual (months 12, 24 and 36), and informal progress reports are due at the ends of months 5, 17, and 29. Financial Reports are due annually.
The invention policy of the Hope Funds for Cancer Research requests adherence by the Fellow to the established patent policy of the Institution where he/she is working. For any discovery made that was funded in any part by a Hope Funds for Cancer Research grant, the Institution shall provide written notification to Hope Funds for Cancer Research within ninety (90) days of the disclosure of any patentable technology, filing of a patent application, or issuance of a patent. In addition, Institutions Technology Transfer Office shall provide a yearly report of the status of the patenting and licensing efforts for each disclosed technology.
In addition, the following documents (PDF) are required of grant awardees:
You must have a valid email address to apply. There is a two-step application process for Hope Fund postdoctoral fellowships. The first step in the application process is to submit a brief description of the proposed research using the Summary of Research Application (writable PDF, which must be saved/printed with added content). We accept electronic signatures on these forms. Please write the 600-word-or-less summary, any allowed figures, and the bibliography (the Fellow’s publications) as a PDF file, and then combine the Summary of Research Application and 600-word-or-less summary, figures and bibliography in one PDF named as “Applicant’s Last Name-Sponsor’s Last Name.pdf”. This should be e-mailed directly to grants@hope-funds.org on or before September 24th of application year.
DO NOT send reference letters for the Abstract Round.
The Grants Review Committee of the Hope Funds for Cancer Research will review these applications and select a short list of candidates. These candidates will be notified directly and be asked to submit a more detailed application package. For those selected, the second step in the application process involves submitting a detailed application package (described below) to the Hope Funds for Cancer Research, 174 Bellevue Avenue, Suite 208, Newport, Rhode Island 02840.
Applicants selected to participate in the second step of the application process should submit the following items, with the pages in the following sequence and numbered consecutively on the bottom right, and with the applicant’s last name and the sponsor’s last name on the bottom left of each page, by January 25th for those selected in the Fall of the application year:
The above application (sections 1 – 5) should be submitted online as a single PDF file and a hard copy of the complete application (sections 1 – 6) should be sent to the Hope Funds for Cancer Research for arrival at our office on or before the deadline. Please name your file as “Applicant’s Last Name-Sponsor’s Last Name.pdf”.
Mail Complete Application (faxed applications will not be considered):
Hope Funds for Cancer Research
174 Bellevue Avenue, Suite 208
Newport, Rhode Island 02840
(401) 847-3286
Referees must directly submit (by e-mail to grants@hope-funds.org) their letters and our Reference Letter Form on or before the application deadline of January 25, 2025. Three (3) letters of reference are required. The Sponsor and two other qualified individuals are asked to evaluate the candidate’s qualifications for the proposed research project and assess the candidate’s potential for successful independent cancer research. Referees are also asked to comment on the originality of the research proposal and the level to which the proposal challenges existing paradigms.
Eligible Countries:
Sponsor Institute/Organizations: Hope Funds for Cancer Research
Sponsor Type:
Address: 174 Bellevue Avenue Suite 208 Newport, RI 02840
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
Jan 25, 2025
Jan 25, 2025
$56,000
Affiliation: Hope Funds for Cancer Research
Address: 174 Bellevue Avenue Suite 208 Newport, RI 02840
Website URL: https://www.hope-funds.org/grants/eligibility-and-application/
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.